
Symtrax SL 1000mg/500mg Injection
Marketer
Symbiosis Pharmaceuticals Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Symtrax SL 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration of Combiflox 1000mg/500mg Injection must be strictly under medical guidance. Adherence to the prescribed dosage schedule is crucial; completing the entire course is vital, even with symptom improvement, as premature cessation can compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Any worsening of these effects necessitates immediate medical consultation. Seek immediate medical attention for allergic reactions such as skin rashes, itching, swelling, or respiratory distress. Inform your physician about all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and sufficient hydration are recommended for optimal recovery. Your doctor may order lab tests to monitor treatment response.
Uses of Symtrax SL 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Symtrax SL 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Symtrax SL 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Symtrax SL 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Symtrax SL 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Symtrax SL 1000mg/500mg Injection, offer a dual-action antibiotic approach. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam, a beta-lactamase inhibitor, complements this by countering bacterial resistance mechanisms, thus potentiating Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Symtrax SL 1000mg/500mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Symtrax SL (1000mg/500mg) is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal to no negative impacts on fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingCAUTION
Administering Symtrax SL 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Symtrax SL 1000mg/500mg Injection could lead to drowsiness, visual disturbances, and dizziness. Refrain from driving if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Symtrax SL 1000mg/500mg Injection in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
The use of Symtrax SL 1000mg/500mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Symtrax SL 1000mg/500mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Symtrax SL 1000mg/500mg Injection :
Omitting a scheduled dose of Symtrax SL 1000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Symtrax SL 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
